Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$45.65
+3.0%
$54.04
$44.05
$109.50
$65.89B0.5622.83 million shs18.68 million shs
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$86.98
+1.3%
$83.70
$72.30
$89.60
$49.45B0.875.00 million shs4.01 million shs
Hologic, Inc. stock logo
HOLX
Hologic
$76.01
$75.56
$51.90
$76.07
$16.97B0.73.29 million shs102.03 million shs
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$541.31
-0.8%
$560.45
$506.91
$769.98
$43.05B1.55620,757 shs652,152 shs
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Boston Scientific Corporation stock logo
BSX
Boston Scientific
+3.05%-2.71%-20.90%-34.50%-55.41%
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
+1.47%-1.79%+1.22%+5.16%+15.47%
Hologic, Inc. stock logo
HOLX
Hologic
0.00%0.00%0.00%+0.65%+17.97%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
-0.81%-5.53%-3.23%-5.98%+3.18%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$45.65
+3.0%
$54.04
$44.05
$109.50
$65.89B0.5622.83 million shs18.68 million shs
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$86.98
+1.3%
$83.70
$72.30
$89.60
$49.45B0.875.00 million shs4.01 million shs
Hologic, Inc. stock logo
HOLX
Hologic
$76.01
$75.56
$51.90
$76.07
$16.97B0.73.29 million shs102.03 million shs
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$541.31
-0.8%
$560.45
$506.91
$769.98
$43.05B1.55620,757 shs652,152 shs
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Boston Scientific Corporation stock logo
BSX
Boston Scientific
+3.05%-2.71%-20.90%-34.50%-55.41%
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
+1.47%-1.79%+1.22%+5.16%+15.47%
Hologic, Inc. stock logo
HOLX
Hologic
0.00%0.00%0.00%+0.65%+17.97%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
-0.81%-5.53%-3.23%-5.98%+3.18%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Boston Scientific Corporation stock logo
BSX
Boston Scientific
2.80
Moderate Buy$85.0886.37% Upside
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
2.81
Moderate Buy$95.9610.32% Upside
Hologic, Inc. stock logo
HOLX
Hologic
2.13
Hold$79.094.05% Upside
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
2.64
Moderate Buy$751.0038.74% Upside

Current Analyst Ratings Breakdown

Latest HOLX, BSX, EW, and IDXX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/16/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Reiterated RatingBuy$65.00
6/16/2026
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
Reiterated RatingOutperform$100.00
6/12/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Reiterated RatingOverweight$65.00
6/5/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
DowngradeHoldStrong Sell
6/4/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Lower Price TargetBuy$85.00 ➝ $64.00
6/2/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Lower Price TargetBuy$80.00 ➝ $65.00
6/2/2026
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
Reiterated RatingBuy$97.00 ➝ $104.00
6/1/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Lower Price TargetBuy$71.00 ➝ $70.00
5/29/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
DowngradeOutperformPeer Perform
5/28/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Reiterated RatingOutperform
5/28/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
Set Price Target$71.00
(Data available from 6/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$20.07B3.38$4.16 per share10.98$16.49 per share2.77
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$6.07B8.25$2.89 per share30.12$17.81 per share4.88
Hologic, Inc. stock logo
HOLX
Hologic
$4.10B4.14$5.74 per share13.25$22.69 per share3.35
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$4.30B9.92$14.97 per share36.17$20.10 per share26.93
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$2.90B$2.3919.1012.340.8517.29%19.17%10.77%7/29/2026 (Estimated)
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$1.07B$1.8846.2725.892.1517.39%15.19%11.71%7/23/2026 (Estimated)
Hologic, Inc. stock logo
HOLX
Hologic
$565.70M$2.4031.6716.452.2413.18%19.58%10.88%N/A
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$1.06B$13.5839.8632.752.9924.63%70.87%32.56%8/3/2026 (Estimated)

Latest HOLX, BSX, EW, and IDXX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/5/2026Q1 2026
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$3.41$3.47+$0.06$3.47$1.12 billion$1.14 billion
4/23/2026Q1 2026
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$0.7280$0.78+$0.0520$0.66$1.60 billion$1.65 billion
4/22/2026Q1 2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$0.7930$0.80+$0.0070$0.90$5.19 billion$5.20 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Boston Scientific Corporation stock logo
BSX
Boston Scientific
N/AN/AN/AN/AN/A
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
N/AN/AN/AN/AN/A
Hologic, Inc. stock logo
HOLX
Hologic
N/AN/AN/AN/AN/A
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Boston Scientific Corporation stock logo
BSX
Boston Scientific
0.42
1.90
1.22
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
0.06
4.42
3.63
Hologic, Inc. stock logo
HOLX
Hologic
0.48
4.04
3.32
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
0.19
1.12
0.82

Institutional Ownership

CompanyInstitutional Ownership
Boston Scientific Corporation stock logo
BSX
Boston Scientific
89.07%
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
79.46%
Hologic, Inc. stock logo
HOLX
Hologic
94.73%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
87.84%

Insider Ownership

CompanyInsider Ownership
Boston Scientific Corporation stock logo
BSX
Boston Scientific
0.34%
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
0.31%
Hologic, Inc. stock logo
HOLX
Hologic
1.88%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
0.79%
CompanyEmployeesShares OutstandingFree FloatOptionable
Boston Scientific Corporation stock logo
BSX
Boston Scientific
59,0001.49 billion1.48 billionOptionable
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
16,000575.80 million574.02 millionOptionable
Hologic, Inc. stock logo
HOLX
Hologic
7,070223.24 million219.05 millionOptionable
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
11,00078.88 million78.26 millionOptionable

Recent News About These Companies

Wall Street Zen Upgrades IDEXX Laboratories (NASDAQ:IDXX) to Buy

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Boston Scientific stock logo

Boston Scientific NYSE:BSX

$45.65 +1.32 (+2.98%)
Closing price 06/23/2026 03:58 PM Eastern
Extended Trading
$45.64 -0.01 (-0.02%)
As of 06:13 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Edwards Lifesciences stock logo

Edwards Lifesciences NYSE:EW

$86.98 +1.10 (+1.28%)
Closing price 06/23/2026 03:58 PM Eastern
Extended Trading
$87.10 +0.11 (+0.13%)
As of 04:03 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Hologic stock logo

Hologic NASDAQ:HOLX

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and connectivity solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, the company offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

IDEXX Laboratories stock logo

IDEXX Laboratories NASDAQ:IDXX

$541.31 -4.42 (-0.81%)
Closing price 06/23/2026 04:00 PM Eastern
Extended Trading
$541.01 -0.30 (-0.06%)
As of 04:06 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.